Cathay Biotech Inc (688065) - Total Liabilities

Latest as of September 2025: CN¥2.23 Billion CNY ≈ $326.05 Million USD

Based on the latest financial reports, Cathay Biotech Inc (688065) has total liabilities worth CN¥2.23 Billion CNY (≈ $326.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Cathay Biotech Inc generate cash to assess how effectively this company generates cash.

Cathay Biotech Inc - Total Liabilities Trend (2016–2024)

This chart illustrates how Cathay Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. Check Cathay Biotech Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Cathay Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Cathay Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Genesis Minerals Ltd AU:GMD	Australia	AU$494.46 Million
Beijing Jingneng Power Co Ltd SHG:600578	China	CN¥67.24 Billion
Glarun Technology Co Ltd SHG:600562	China	CN¥3.45 Billion
Sectra AB (publ) ST:SECT-B	Sweden	Skr1.71 Billion
CHINA TOWER UNSP.ADR/100 F:2Y10	Germany	€130.77 Billion
Housing & Urban Development Corporation Limited NSE:HUDCO	India	Rs1.31 Trillion
Corporacion Financiera Alba SA MC:ALB	Spain	€687.00 Million
Red Avenue New Materials Group Co Ltd SHG:603650	China	CN¥5.43 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Cathay Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688065 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.94	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cathay Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cathay Biotech Inc (2016–2024)

The table below shows the annual total liabilities of Cathay Biotech Inc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.92 Billion ≈ $573.68 Million	-3.44%
2023-12-31	CN¥4.06 Billion ≈ $594.14 Million	+45.58%
2022-12-31	CN¥2.79 Billion ≈ $408.13 Million	+84.61%
2021-12-31	CN¥1.51 Billion ≈ $221.07 Million	+132.16%
2020-12-31	CN¥650.74 Million ≈ $95.22 Million	-51.43%
2019-12-31	CN¥1.34 Billion ≈ $196.07 Million	-20.38%
2018-12-31	CN¥1.68 Billion ≈ $246.26 Million	+79.68%
2017-12-31	CN¥936.58 Million ≈ $137.05 Million	+113.24%
2016-12-31	CN¥439.21 Million ≈ $64.27 Million	--

About Cathay Biotech Inc

SHG:688065 China Chemicals

Market Cap

$5.02 Billion

CN¥34.33 Billion CNY

Market Cap Rank

#3614 Global

#578 in China

Share Price

CN¥47.60

Change (1 day)

-0.56%

52-Week Range

CN¥45.43 - CN¥62.24

All Time High

CN¥134.07